Revolutionizing tumor immunotherapy: unleashing the power of progenitor exhausted T cells
Z Fang, X Ding, H Huang, H Jiang… - Cancer Biology & …, 2024 - cancerbiomed.org
In exploring persistent infections and malignancies, a distinctive subgroup of CD8+ T cells,
progenitor exhausted CD8+ T (Tpex) cells, has been identified. These Tpex cells are notable …
progenitor exhausted CD8+ T (Tpex) cells, has been identified. These Tpex cells are notable …
PD-1+ T lymphocyte proportions and hospitalized exacerbation of COPD: a prospective cohort study
H Xue, X Lan, T Xue, X Tang, H Yang, Z Hu, N Xu… - Respiratory …, 2024 - Springer
Objective To evaluate the predictive value of PD-1 expression in T lymphocytes for
rehospitalization due to acute exacerbations of COPD (AECOPD) in discharged patients …
rehospitalization due to acute exacerbations of COPD (AECOPD) in discharged patients …
Functional impairment of" helpless" CD8+ memory T cells is transient and driven by prolonged but finite cognate antigen presentation
V van der Heide, B Davenport, B Cubitt, V Roudko… - bioRxiv, 2024 - biorxiv.org
Generation of functional CD8+ T cell memory typically requires engagement of CD4+ T cells.
However, in certain scenarios, such as acutely-resolving viral infections, effector (TE) and …
However, in certain scenarios, such as acutely-resolving viral infections, effector (TE) and …
Combined Dendritic Cell And Anti-TIGIT Immunotherapy Potentiate Trail+ Memory NK Cells Against HIV-1 Infected Cells
IS Cerrillo, O Popova, MA Lera, I Tsukalov… - bioRxiv, 2024 - biorxiv.org
Natural Killer (NK) cells are promising tools for the development of immunotherapies
targeting persistently infected CD4+ T cells to potentially achieve remission in people with …
targeting persistently infected CD4+ T cells to potentially achieve remission in people with …
DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8+ T cells
Z Yu, V Sasidharan-Nair, A Bonifacius, F Khan… - bioRxiv, 2023 - biorxiv.org
Epigenetic mechanisms stabilize gene expression patterns during CD8+ T cell
differentiation. However, although adoptive transfer of virus-specific T cells is clinically …
differentiation. However, although adoptive transfer of virus-specific T cells is clinically …
Human effector CD8+ T cells with an exhausted-like phenotype control tumor growth in vivo in a humanized tumor model
Background Humanized tumor models could be particularly valuable for cancer
immunotherapy research, as they may better reflect human-specific aspects of the interfaces …
immunotherapy research, as they may better reflect human-specific aspects of the interfaces …
Sex differences in vaccine induced immunity and protection against Mycobacterium tuberculosis
GH Parvathy, D Bhandiwad, L Eggers, L von Borstel… - bioRxiv, 2024 - biorxiv.org
Tuberculosis (TB) is a disease that has evolved with humankind for millennia, causing
approximately 1.3 million deaths worldwide per annum. Although increased male affliction …
approximately 1.3 million deaths worldwide per annum. Although increased male affliction …
Investigating the role of lectins in LAG3 function and T cell activity
SF Mohideen - 2024 - mspace.lib.umanitoba.ca
During prolonged antigen exposure, as in cancer or HIV, surface inhibitory receptors called
immune checkpoints (ICs), like Lymphocyte Activation Gene-3 (LAG3) are upregulated on T …
immune checkpoints (ICs), like Lymphocyte Activation Gene-3 (LAG3) are upregulated on T …
[PDF][PDF] Human effector CD8+ T cells with an exhausted-like phenotype control tumor growth in vivo
Abstract 1 The functional relevance of CD8+ T cell phenotypes in human cancer is not well
established. 2 In preclinical studies, murine CD8+ T cells exhibiting an exhausted-like …
established. 2 In preclinical studies, murine CD8+ T cells exhibiting an exhausted-like …
PD-L1 at the crossroad between RNA metabolism and immunosuppression
A Arthur, S Nejmi, DM Franchini, E Espinos… - Trends in Molecular …, 2024 - cell.com
Abstract Programmed death ligand-1 (PD-L1) is a key component of tumor
immunosuppression. The uneven therapeutic results of PD-L1 therapy have stimulated …
immunosuppression. The uneven therapeutic results of PD-L1 therapy have stimulated …